Delisting risk
Calidi Biotherapeutics
Develops systemic oncolytic-virus platforms that deliver therapeutic payloads into tumors.
$1.32
After-hours close+0.01 (+0.76%)
At close$1.31(+0.77%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 27.27%Insiders —
Shares outstanding 460.4K · Float 343.8K · 74.7% free float
Institutions13F, as of Mar 31, 2026
29 holders · 125.6K shares · 8 new positions · 15 increased · 3 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 54.9K | 11.93% | +54.9Knew | May 15, 2026 |
| Sabby Management, LLC | 27.2K | 5.90% | +27.2Knew | May 15, 2026 |
| Warberg Asset Management LLC | 15.6K | 3.39% | +15.6K | May 7, 2026 |
| Hightower Advisors, LLC | 5.2K | 1.13% | 0 | May 5, 2026 |
| Virtu Financial LLC | 4.7K | 1.03% | +3.4K | May 14, 2026 |
| Geode Capital Management, LLC | 3.9K | 0.86% | +1.3K | May 15, 2026 |
| RS Crum Inc. | 2.5K | 0.55% | +1.3K | Apr 15, 2026 |
| SRS Capital Advisors, Inc. | 2.3K | 0.51% | +2.3Knew | May 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 13G | May 15, 2026 ↗ | |
| Funicular Funds, LPincl. Cable Car Capital LLC, Jacob Ma-Weaver | 9.99% | Sep 11, 2024 ↗ |
InsidersForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.